Mode
Text Size
Log in / Sign up

Watch-and-wait after total neoadjuvant therapy shows comparable oncologic outcomes to surgery for rectal cancerWatch and wait approach shows promise for rectal cancer patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that watch-and-wait after neoadjuvant therapy may offer comparable oncologic outcomes and better organ preservation.

The meta-analysis evaluated the efficacy of watch-and-wait strategies compared to standard total mesorectal excision in patients with locally advanced rectal cancer who had received total neoadjuvant therapy. The primary focus was on oncologic outcomes, including local recurrence and distant metastases, alongside organ-preservation metrics such as the rate of permanent stomas.

Results indicated no significant differences between the two groups regarding local recurrence, distant metastases, or overall survival. However, a lower rate of permanent stoma was observed in the watch-and-wait cohort, a finding that became more pronounced during sensitivity analysis. These results suggest that watch-and-wait may offer a viable alternative for specific patients to preserve organ function without compromising oncologic safety.

Several limitations were noted, including high heterogeneity in both local recurrence and permanent stoma data. Furthermore, the inclusion of observational studies means the results represent associations rather than definitive evidence of causation. Clinicians should consider these findings as a potential pathway for highly selected patients, while remaining mindful of the inherent limitations of the underlying data.

Living with rectal cancer often involves a difficult choice about surgery. For many, the fear of a permanent stoma, or a permanent opening in the abdomen, is a major concern. New data suggests that for certain patients, a 'watch and wait' approach after intensive initial treatment might offer a way to preserve the body while still fighting the cancer effectively.

Researchers looked at 793 patients with locally advanced rectal cancer who received total neoadjuvant therapy. This is a heavy upfront treatment involving chemotherapy and radiation. The study compared those who went straight to surgery with those who were monitored closely after their initial treatment. The results showed that both groups had similar rates of cancer survival and similar chances of the cancer returning.

One key finding was that the 'watch and wait' group had fewer permanent stomas. While the data was varied across different studies, a closer look at the numbers confirmed this trend. Because these results come from a mix of different studies, the findings are not definitive, but they suggest that for carefully chosen patients, skipping immediate surgery might offer better quality of life without sacrificing safety.

What this means for you:
Watch and wait after intensive treatment may reduce the need for permanent stomas in some rectal cancer patients.

Common questions

Does the watch and wait approach lower the risk of cancer returning?

The study of 793 patients found no significant difference in local recurrence or distant metastases between those who were watched and those who had immediate surgery. Both groups showed similar five-year disease-free survival and overall survival rates.

Can this treatment help patients avoid a permanent stoma?

Patients who followed the watch and wait path after their initial treatment had lower rates of permanent stoma. While the initial data was varied, a more specific analysis confirmed that this group had fewer permanent stomas than those who went straight to surgery.

Who is this treatment intended for?

This approach is intended for patients with locally advanced rectal cancer who have received total neoadjuvant therapy. It is most effective for highly selected patients where the goal is to preserve the organ and reduce surgical complications.

Study Details

Study typeMeta analysis
Sample sizen = 793
EvidenceLevel 1
Follow-up60.0 mo
PublishedOct 2026
View Original Abstract ↓
BackgroundTotal neoadjuvant therapy (TNT) increases clinical complete response rates in locally advanced rectal cancer (RC), allowing response-based management strategies such as watch-and-wait (WW) as an alternative to total mesorectal excision (TME). Outcomes associated with WW after TNT remain incompletely defined. This study aimed to compare oncologic and organ-preservation outcomes between WW and surgical management following TNT.MethodsA systematic search was conducted in PubMed, Scopus, and Cochrane Central up to April 2025. Observational studies comparing WW and TME following TNT were included. Pooled odds ratios (ORs), hazard ratios (HRs), and 95% confidence intervals (CIs) were calculated using a random-effects model. Heterogeneity was assessed with I statistics. Secondary outcomes included tumor regrowth, salvage surgery, and permanent stoma. Risk of bias was evaluated using ROBINS-I.ResultsSix studies comprising 793 patients were analyzed. WW showed no significant difference compared with TME regarding local recurrence (OR 1.36, 95% CI 0.07-26.17; I = 80%), distant metastases (OR 0.62, 95% CI 0.29-1.33; I = 49%), 5-year disease-free survival (HR 0.97, 95% CI 0.71-1.31; I = 51.7%), or overall survival (HR 1.03, 95% CI 0.81-1.30; I = 27.9%). Permanent stoma rates were lower with WW (OR 0.12, 95% CI 0.01-1.23; I = 71%), becoming significant after sensitivity analysis (OR 0.04, 95% CI 0.01-0.19).ConclusionWW after TNT offers oncologic outcomes comparable to TME, with high organ preservation and reduced surgical morbidity in highly selected patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.